Close

TRIM29

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

TRIM29 belongs to the TRIM protein family. It has multiple zinc finger motifs and a leucine zipper motif. It has been proposed to form homo- or heterodimers which are involved in nucleic acid binding. Thus, TRIM29 may act as a transcriptional regulatory factor involved in carcinogenesis and/or differentiation. TRIM29 may also function in the suppression of radiosensitivity since it is associated with ataxia telangiectasia phenotype.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YJ369 Anti-TRIM29 (TPMP29-1) h(41BB-CD3ζ) CAR, pCDCAR1 Human TPMP29-1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ370 Anti-TRIM29 (TRIM29/1041) h(41BB-CD3ζ) CAR, pCDCAR1 Human TRIM29/1041 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ371 Anti-TRIM29 (TRIM29/1042) h(41BB-CD3ζ) CAR, pCDCAR1 Human TRIM29/1042 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ869 Anti-TRIM29 (TPMP29-1) h(CD28-CD3ζ) CAR, pCDCAR1 Human TPMP29-1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ870 Anti-TRIM29 (TRIM29/1041) h(CD28-CD3ζ) CAR, pCDCAR1 Human TRIM29/1041 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ871 Anti-TRIM29 (TRIM29/1042) h(CD28-CD3ζ) CAR, pCDCAR1 Human TRIM29/1042 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.